Evogene Ltd. (EVGN)
0.5076
-0.03
(-5.63%)
USD |
NASDAQ |
Sep 08, 16:00
0.5002
-0.01
(-1.46%)
After-Hours: 20:00
Evogene Total Assets (Quarterly) : 13.44M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.44M |
| March 31, 2026 | 17.95M |
| December 31, 2025 | 20.05M |
| September 30, 2025 | 26.09M |
| June 30, 2025 | 33.93M |
| March 31, 2025 | 34.30M |
| December 31, 2024 | 39.86M |
| September 30, 2024 | 40.11M |
| June 30, 2024 | 40.97M |
| March 31, 2024 | 46.78M |
| December 31, 2023 | 51.10M |
| September 30, 2023 | 57.75M |
| June 30, 2023 | 53.34M |
| March 31, 2023 | 49.48M |
| December 31, 2022 | 56.13M |
| September 30, 2022 | 59.39M |
| June 30, 2022 | 56.66M |
| March 31, 2022 | 66.88M |
| December 31, 2021 | 76.30M |
| September 30, 2021 | 83.39M |
| June 30, 2021 | 87.54M |
| March 31, 2021 | 92.78M |
| December 31, 2020 | 71.92M |
| September 30, 2020 | 65.98M |
| June 30, 2020 | 61.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 64.64M |
| December 31, 2019 | 71.36M |
| September 30, 2019 | 76.44M |
| June 30, 2019 | 53.45M |
| March 31, 2019 | 57.64M |
| December 31, 2018 | 58.69M |
| September 30, 2018 | 63.67M |
| June 30, 2018 | 68.09M |
| March 31, 2018 | 72.05M |
| December 31, 2017 | 77.60M |
| September 30, 2017 | 83.10M |
| June 30, 2017 | 87.45M |
| March 31, 2017 | 91.90M |
| December 31, 2016 | 95.99M |
| September 30, 2016 | 101.78M |
| June 30, 2016 | 105.93M |
| March 31, 2016 | 109.03M |
| December 31, 2015 | 112.60M |
| September 30, 2015 | 116.37M |
| June 30, 2015 | 119.86M |
| March 31, 2015 | 123.44M |
| December 31, 2014 | 127.59M |
| September 30, 2014 | 129.76M |
| June 30, 2014 | 131.86M |
| March 31, 2014 | 133.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Compugen Ltd. | 138.36M |
| Pluri, Inc. | 26.06M |
| Scinai Immunotherapeutics Ltd. | 17.17M |
| CollPlant Biotechnologies Ltd. | 9.183M |
| Regentis Biomaterials Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.542M |
| Shareholders Equity (Quarterly) | -3.29M |
| Debt to Equity Ratio | -0.6386 |
| Current Ratio | 3.566 |
| Net Debt Paydown Yield | 1.65% |